Vernal Keratoconjunctivitis Overview

Save information for later
Sign Up

Learn About Vernal Keratoconjunctivitis

What is the definition of Vernal Keratoconjunctivitis?
Vernal keratoconjunctivitis (VKC) is a chronic, severe allergy that affects the surfaces of the eyes. It most commonly occurs in boys living in warm, dry climates. Attacks associated with VKC are common in the spring (hence the name "vernal") and summer but often reoccur in the winter. It is caused by a hypersensitivity (allergic reaction) to airborne-allergens.
What are the alternative names for Vernal Keratoconjunctivitis?
  • Vernal keratoconjunctivitis
  • VKC
Who are the top Vernal Keratoconjunctivitis Local Doctors?
Elite in Vernal Keratoconjunctivitis
Andrea Leonardi
Elite in Vernal Keratoconjunctivitis
Andrea Leonardi
Padova, IT 

Andrea Leonardi practices in Padova, Italy. Ms. Leonardi is rated as an Elite expert by MediFind in the treatment of Vernal Keratoconjunctivitis. Her top areas of expertise are Giant Papillary Conjunctivitis, Allergic Conjunctivitis, Vernal Keratoconjunctivitis, and Conjunctivitis (Pink Eye).

Elite in Vernal Keratoconjunctivitis
Nobuyuki Ebihara
Elite in Vernal Keratoconjunctivitis
Nobuyuki Ebihara
Urayasu, JP 

Nobuyuki Ebihara practices in Urayasu, Japan. Mr. Ebihara is rated as an Elite expert by MediFind in the treatment of Vernal Keratoconjunctivitis. His top areas of expertise are Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Allergic Conjunctivitis, Vitrectomy, and Trabeculectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Vernal Keratoconjunctivitis
Akira Matsuda
Elite in Vernal Keratoconjunctivitis
Akira Matsuda
Tokyo, JP 

Akira Matsuda practices in Tokyo, Japan. Matsuda is rated as an Elite expert by MediFind in the treatment of Vernal Keratoconjunctivitis. Their top areas of expertise are Allergic Conjunctivitis, Giant Papillary Conjunctivitis, Vernal Keratoconjunctivitis, Trabeculectomy, and Vitrectomy.

View All Doctors
What are the latest Vernal Keratoconjunctivitis Clinical Trials?
A Randomized Controlled Trial on the Effects of Oral Kelulut Honey Supplementation on Conjunctival Goblet Cell Density, Tear Film Stability, Dry Eye Disease Symptoms and Vision-Related Function in Patients With Allergic Conjunctivitis
A Randomized Controlled Trial on the Effects of Oral Kelulut Honey Supplementation on Conjunctival Goblet Cell Density, Tear Film Stability, Dry Eye Disease Symptoms and Vision-Related Function in Patients With Allergic Conjunctivitis
Enrollment Status: Recruiting
Publish Date: December 09, 2025
Intervention Type: Dietary supplement, Other
Study Phase: Not Applicable

Summary: The goal of this clinical trial is to learn if oral Kelulut honey works to improve eye symptoms in adults with allergic conjunctivitis. It will also look at how safe Kelulut honey is when taken as a daily supplement. The main questions it aims to answer are: 1. Does oral Kelulut honey reduce itchy, red, watery eyes and dry eye symptoms in people with allergic conjunctivitis? 2. Does oral Kelulut h...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Single Center, Randomized, Double-masked, Vehicle Controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Seasonal Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model
A Single Center, Randomized, Double-masked, Vehicle Controlled Phase 2 Study Evaluating the Safety and Efficacy of TL-925 Ophthalmic Emulsion 0.1% Compared to Vehicle for the Treatment of Seasonal Allergic Conjunctivitis in the Conjunctival Allergen Challenge (Ora-CAC®) Model
Enrollment Status: Recruiting
Publish Date: November 25, 2025
Intervention Type: Drug
Study Phase: Phase 2

Summary: In this prospective, Phase 2, randomized, double-masked, vehicle controlled study, approximately 60 eligible subjects will be randomized 1:1 to receive either TL-925 or placebo as topical ophthalmic eye drops administered bilaterally. The study comprises of a screening and treatment period using the conjunctival allergen challenge model to evaluate TL-925 for the treatment of allergic conjunctivit...

View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center